yep I like the term “best bang for buck” rather than the other opportunities not being worthwhile, but as you say need to be prioritised.
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-57
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
-0.020(1.41%) |
Mkt cap ! $242.0M |
Open | High | Low | Value | Volume |
$1.43 | $1.43 | $1.40 | $88.73K | 62.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 141 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.42 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 141 | 1.400 |
1 | 5998 | 1.385 |
1 | 1000 | 1.380 |
1 | 5000 | 1.370 |
1 | 1279 | 1.365 |
Price($) | Vol. | No. |
---|---|---|
1.415 | 1 | 1 |
1.425 | 1 | 1 |
1.445 | 14632 | 2 |
1.450 | 38352 | 1 |
1.480 | 3055 | 2 |
Last trade - 11.28am 15/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online